A practical checklist for evaluating decentralized trial technology vendors, built from an RF engineer’s view of where data quality actually breaks.
- Decentralized Trials Promised Less Burden. Did They Deliver?
- Wireless Connectivity Is A Data Integrity Issue, Not IT
- Why Clinical AI Validation Needs Portability Testing Beyond A Single Accuracy Score
- The Synchronization Problem Clinical Research Isn't Watching
- Why Ophthalmology Trials Are Clinical Research's Toughest Tech Test
- Why Trustworthy Clinical Trial Data Starts As Analog, Not Digital
- Why Clinical Trial Coordinators Are Still The Human API
- The Cost And ROI Of Agentic AI In Clinical Trials: What Sponsors And CROs Need To Know
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Paper COAs in 2026: It's Not Cheaper, It's Riskier
Learn why sticking with paper records is a faulty strategy and discover how hidden costs, transcription errors, and regulatory red flags make digital COAs the only safe choice for modern trials.
-
Expedite Drug Development With An Integrated CDMO-CRO Model
From optimizing first-in-human strategies to leveraging AI-enabled digital architectures, the integrated CDMO-CRO services model reduces risk and maximizes program value.
-
AI's Bottleneck In Clinical Trials Moved, And Most People Missed It
AI has accelerated drug discovery, but the real bottleneck is now clinical trial operations. Explore why regulatory success depends on auditable data governance, not model speed.
-
Accelerating Study Startups: Drive Efficiency From Protocol To Go-Live
Speed up trial launches and maintain predictable timelines by leveraging a modern, integrated approach to eCOA setup that reduces complexity.
-
5 Ways Lab Data Can Help Commercialize Your Therapy
Delve into five pivotal insights for leveraging lab data effectively and the collaboration that accelerated market entry for new therapies while ensuring the needs of targeted populations were met.
-
The Vendor Selection Blunder: An Expensive Oversight In Clinical Trials
Vendor selection isn’t just procedural — it shapes trial outcomes. Even with a solid process, missteps can ripple through timelines, budgets, and team morale. Choose wisely.
-
Accelerating Your New Therapies Path To Market With Automation
Automation has become an essential tool for addressing the inefficiencies in traditional clinical trial methodologies, enabling trial teams to instead concentrate on critical tasks such as patient care.
-
How To Reduce Risk And Effort When Migrating A TMF
Utilize this summary of key tips, checklists, and lessons learned to mitigate the risks and efforts associated with migrating a trial master file.
-
Enhancing The Patient Journey In Clinical Trials
Utilize supportive data to overcome the challenges of implementing a patient-focused approach to clinical trials and enhance your trial outcomes, advancing research and improving the patient journey.
-
How To Migrate Active Studies To A New EDC
Gain access to the results and lessons learned from a project involving the modernization of an electronic data capture system and mid-study data migrations.
RECENT NEWSLETTERS
- 08.20.26 -- Clinical AI Validation, Trial Handoffs, And Smarter Study Builds
- 08.13.26 -- AI Urgency, Site-Sponsor Gaps, And Data That Saves Lives
- 08.06.26 -- Clinical Trial Tech: AI, Data Quality, And Faster Study Build
- 08.01.26 -- July's Top Clinical Trial Tech Reads
- 07.30.26 -- Clinical Tech Leadership: Site Burden, AI ROI, And Smarter Trial Tech